MedTrace Logo

Thermage FLX System to Treat the Face, Neck, and Eyelids

NCT03894371 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2019-03-28

No results posted yet for this study

Summary

25 subjects Fitzpatrick skin type I-VI with mild to moderate laxity of the skin of the face, neck, and eyelids will be enrolled. All subjects will undergo treatment with the Thermage FLX system using a 900 pulse, 4cm2 Total Tip to treat the face and neck and a 450 pulse, 0.25cm2 tip to treat the upper and lower eyelids.

Conditions

  • Facial Skin Laxity

Interventions

DEVICE

Thermage FLX

Thermage FLX system for the correction of mild to moderate laxity of the skin of the face, neck, and eyelids.

Sponsors & Collaborators

  • Bausch Health

    collaborator UNKNOWN

  • Nashville Centre for Laser and Facial Surgery

    lead OTHER

Principal Investigators

  • Brian S Biesman, MD · The Practice of Brian S. Biesman, MD

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
25 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-04-01
Primary Completion
2019-11-01
Completion
2019-12-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03894371 on ClinicalTrials.gov